Connect your AI

LivaNova LIVN Contract Liabilities

Contract Liabilities at other companies

HaemoneticsHAE

$44.6M+25.3%

ITG

Integer HoldingsITGR

$3.03M-15.4%

ResMedRMD

$163.15M+8.0%

Merit Medical SystemsMMSI

$1.37M-7.0%

MedtronicMDT

——

Globus MedicalGMED

——

Other financials

Income statement

Revenue$362.3M+14.3%

Gross profit$243.7M+12.7%

Operating income$41.5M-14.7%

Net income$22.3M+107%

EPS (diluted)$0.40+107%

Balance sheet

Cash & equivalents$539.7M-26.9%

Total debt$340.9M-49.7%

Total equity$1.2B+17.1%

Total assets$2.5B-1.7%

Cash flow

Operating cash flow$15.2M-36.5%

CapEx$14.3M+32.4%

Free cash flow$926.0K-93.0%

Valuation

Market cap$4.32B+62.8%

Profitability

Gross margin67.5%-0.5pp

Operating margin13.4%+0.8pp

Net margin-16.1%-18.0pp

FCF margin11.2%-0.2pp

Returns & leverage

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.4×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LivaNova's contract liabilities?: LivaNova (LIVN) reported contract liabilities of $20.8M in Q1 2026.
How has LivaNova's contract liabilities changed year-over-year?: LivaNova's contract liabilities increased by 35.1% year-over-year, from $15.4M to $20.8M.
What is the long-term trend for LivaNova's contract liabilities?: Over 5 years (2020 to 2025), LivaNova's contract liabilities has grown at a 15.8% compound annual growth rate (CAGR), from $8.6M to $17.9M.
What does contract liabilities mean?: Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.